<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/2021.07.14.452299</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;2021.07.14.452299</article-id><article-id pub-id-type="other" hwp:sub-type="slug">2021.07.14.452299</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">2021.07.14.452299</article-id><article-id pub-id-type="other" hwp:sub-type="tag">2021.07.14.452299</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Immunology" hwp:journal="biorxiv"><subject>Immunology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">CIITA induces expression of MHC-I and MHC-II in transmissible cancers</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label><bold>Correspondence Andrew S. Flies, PhD</bold>, Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, phone: +61 3 6226 4614; email: <email hwp:id="email-1">Andy.Flies@utas.edu.au</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4149-2596</contrib-id><name name-style="western" hwp:sortable="Ong Chrissie E. B."><surname>Ong</surname><given-names>Chrissie E. B.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-4149-2596"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Cheng Yuanyuan"><surname>Cheng</surname><given-names>Yuanyuan</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Siddle Hannah V."><surname>Siddle</surname><given-names>Hannah V.</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8508-5853</contrib-id><name name-style="western" hwp:sortable="Lyons A. Bruce"><surname>Lyons</surname><given-names>A. Bruce</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-8508-5853"/></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Woods Gregory M."><surname>Woods</surname><given-names>Gregory M.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-6"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4550-1859</contrib-id><name name-style="western" hwp:sortable="Flies Andrew S."><surname>Flies</surname><given-names>Andrew S.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-4550-1859"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3"><label>1</label><institution hwp:id="institution-1">Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania</institution>, Hobart, TAS, <country>Australia</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1"><label>2</label><institution hwp:id="institution-2">School of Life and Environmental Sciences, The University of Sydney</institution>, Sydney, NSW, <country>Australia</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1"><label>3</label><institution hwp:id="institution-3">Department of Biological Sciences, University of Southampton</institution>, Southampton, <country>UK</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1"><label>4</label><institution hwp:id="institution-4">Institute for Life Sciences, University of Southampton</institution>, Southampton, <country>UK</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1"><label>5</label><institution hwp:id="institution-5">Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania</institution>, Hobart, TAS, <country>Australia</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2021-07-14T13:42:15-07:00">
    <day>14</day><month>7</month><year>2021</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-10-24T23:15:13-07:00">
    <day>24</day><month>10</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2021-07-14T13:46:56-07:00">
    <day>14</day><month>7</month><year>2021</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-10-24T23:20:34-07:00">
    <day>24</day><month>10</month><year>2021</year>
  </pub-date><elocation-id>2021.07.14.452299</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2021-07-14"><day>14</day><month>7</month><year>2021</year></date>
<date date-type="rev-recd" hwp:start="2021-10-24"><day>24</day><month>10</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-10-24"><day>24</day><month>10</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license hwp:id="license-1"><p hwp:id="p-1">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="452299.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/change-list" xlink:role="change-list" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/2021.07.14.452299v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="452299.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/2021.07.14.452299v2/2021.07.14.452299v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/2021.07.14.452299v2/2021.07.14.452299v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">MHC-I and MHC-II molecules are critical components of antigen presentation and T cell immunity to pathogens and cancer. The two monoclonal transmissible devil facial tumours (DFT1, DFT2) exploit MHC-I pathways to overcome immunological anti-tumour and allogeneic barriers. This exploitation underpins the ongoing transmission of DFT cells across the wild Tasmanian devil population. We have previously shown that constitutive expression of NLRC5 can induce stable upregulation of MHC-I on DFT1 and DFT2 cells, but unlike IFNG-treated cells, NLRC5 does not upregulate PDL1. MHC-II expression is crucial for CD4<sup>+</sup> T cell activation and is primarily confined to haematopoietic antigen presenting cells. Transcriptomic analysis of DFT1 and DFT2 cell lines showed that several genes of the MHC-I and MHC-II pathways were upregulated in response to constitutive overexpression of the class II transactivator (CIITA) gene. This was further supported by upregulation of MHC-I protein on DFT1 and DFT2 cells, but interestingly MHC-II protein was upregulated only on DFT1 cells. The functional significance of the MHC upregulation on DFT cells was shown using serum from devils with natural or immunotherapy-induced DFT1 regressions; binding of serum IgG was stronger in CIITA-transfected cells than wild type cells, but was less than binding to NLRC5 transfected cells. This new insight into regulation of MHC-I and MHC-II in cells that naturally overcome allogeneic barriers can inform vaccine, immunotherapy, and tissue transplant strategies for human and veterinary medicine.</p></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-2">Keywords</title><kwd hwp:id="kwd-1">transmissible cancer</kwd><kwd hwp:id="kwd-2">devil facial tumour</kwd><kwd hwp:id="kwd-3">DFTD</kwd><kwd hwp:id="kwd-4">allograft</kwd><kwd hwp:id="kwd-5">MHC</kwd><kwd hwp:id="kwd-6">CIITA</kwd></kwd-group><counts><page-count count="28"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-3">Competing Interest Statement</title><p hwp:id="p-3">The authors have declared no competing interest.</p></notes><fn-group content-type="summary-of-updates" hwp:id="fn-group-1"><title hwp:id="title-4">Summary of Updates:</title><fn fn-type="update" hwp:id="fn-1"><p hwp:id="p-4">Title changed to "CIITA induces expression of MHC-I and MHC-II in transmissible cancers".</p></fn></fn-group></notes></front><body><sec id="s1" hwp:id="sec-1"><label>1.</label><title hwp:id="title-5">Introduction</title><p hwp:id="p-5">The Tasmanian devil is the largest extant carnivorous marsupial and is endemic to the island state of Tasmania. Following the emergence of devil facial tumour disease (DFTD) in 1996, the population of devils has declined precipitously, threatening the persistence of devils in the wild<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref></sup>. DFTD is caused by two independent transmissible cancers of Schwann cell origin, referred herein as DFT1 and DFT2<sup><xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>,<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref></sup>. DFT1 was discovered northeast of Tasmania in 1996 while the second tumour, DFT2, was found in 2014 in the D’Entrecasteaux channel, southeast Tasmania. Both tumour types are clonal cell lines that harbour distinct genetic profiles differing from individual host devils<sup><xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-2" hwp:rel-id="ref-2">2</xref>,<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref></sup>. DFT cells are transmitted as a malignant allograft amongst devils through social interactions.</p><p hwp:id="p-6">Genetic differences between host and tumour, particularly at the major histocompatibility complex (MHC) loci<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref></sup>, should induce immune-mediated allograft rejection. However, the 25 years of ongoing DFT1 transmission suggests that DFT1 cells have evolved to evade immune defences. The lack of anti-DFT immune responses has predominantly focused on the loss of MHC-I from the surface of DFT1 cells. This occurs via epigenetic downregulation of several components of the MHC-I antigen processing pathway<sup><xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref></sup> and a hemizygous deletion of beta-2 microglobulin (<italic toggle="yes">B2M</italic>), which is necessary for stabilising MHC-I complexes on the cell surface<sup><xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref></sup>. Natural and immunotherapy-induced tumour regressions have been observed in devils, along with antibody responses to DFT1 cells, albeit primarily in the context of MHC-I<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>–<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref></sup>. Conversely, the emerging DFT2 tumours do express MHC-I<sup><xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref></sup>, suggesting that other immune evasion mechanisms are important.</p><p hwp:id="p-7">Given the role of MHC-I in antigen display and anti-DFT humoral response, the manipulation of MHC-I expression on DFT cells is an attractive target to improve host responses towards DFT cells and mitigate the effects of disease in the wild devil population. An upregulation of MHC-I on DFT cells should enhance MHC-I-restricted tumour-specific cytotoxic CD8<sup>+</sup> T cell response. However, this approach alone proved to be insufficient for eliciting protective immunity, as exemplified in immunisation trials of naïve devils against DFT1<sup><xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-2" hwp:rel-id="ref-9">9</xref></sup>. Although CD8<sup>+</sup> T cells are recognised as the major effector cells in tumour elimination, CD4<sup>+</sup> T cell help is critical in facilitating an effective anti-tumour immune response. CD4<sup>+</sup> helper T cells play a multifaceted role of orchestrating the adaptive and humoral immune response. From cytokine production to expression of co-stimulatory molecules, CD4<sup>+</sup> helper T cells initiate, augment, and sustain the effector function of not only CD8<sup>+</sup> T cells and B cells but also innate cells<sup><xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>–<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref></sup>. Moreover, CD4<sup>+</sup> T cells are capable of initiating allograft rejection independently of CD8<sup>+</sup> T cells<sup><xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>,<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref></sup>.</p><p hwp:id="p-8">The activation of CD4<sup>+</sup> T cells involves recognition of antigens presented on MHC-II complexes. In contrast to MHC-I, constitutive expression of MHC-II is restricted to thymic epithelial cells, activated human T cells, and professional antigen presenting cells (APCs) such as B cells, dendritic cells, and macrophages. However, <italic toggle="yes">de novo</italic> MHC-II expression can be induced in non-haematopoietic cells including tumour cells by the inflammatory cytokine interferon gamma (IFNG)<sup><xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref></sup>. Both constitutive and IFNG-induced expression of MHC-II genes are mediated by the Class II transactivator (CIITA), making it the master regulator of MHC-II expression<sup><xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>,<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref></sup>. Additionally, CIITA is capable of modulating the expression of MHC-I, particularly in cell lines with low to no MHC-I expression<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>,<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref></sup>.</p><p hwp:id="p-9">The presence of MHC-II molecules in DFT cells has not been described, although CIITA and some MHC-II transcripts can be upregulated <italic toggle="yes">in vitro</italic> in DFT1 cells with IFNG treatment<sup><xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-2" hwp:rel-id="ref-5">5</xref></sup>. We have previously genetically modified DFT1 and DFT2 cells that overexpress the MHC-I transactivator NLRC5 to induce stable expression of MHC-I on the cell surface<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref></sup>. The lack of MHC-II expression in DFT cells provided an opportunity to conduct similar investigations into the role of CIITA in MHC-II regulation in marsupials and transmissible cancers. Transcriptomic and protein-based analyses showed that CIITA upregulates the expression of genes associated with MHC-I and MHC-II antigen processing and presentation in DFT cells. The ability to modulate antigen presentation in transmissible cancer cells in the context of MHC uncovers additional targets for anti-tumour immune response and the potential for recruitment of CD4<sup>+</sup> T cell help.</p></sec><sec id="s2" hwp:id="sec-2"><label>2.</label><title hwp:id="title-6">Materials and methods</title><sec id="s2a" hwp:id="sec-3"><label>2.1</label><title hwp:id="title-7">Cells and cell culture conditions</title><p hwp:id="p-10">Cell lines that were used in this study include DFT1 cell line C5065 strain 3<sup><xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref></sup> (RRID:CVCL_LB79), and DFT2 cell lines: RV (RRID:CVCL_LB80) and JV (RRID:CVCL_A1TN)<sup><xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-3" hwp:rel-id="ref-3">3</xref></sup> (<bold><xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref></bold>). DFT1 C5065 was provided by A-M Pearse and K. Swift of the Department of Primary Industries, Parks, Water and Environment (DPIPWE) (Hobart, TAS, Australia) and was previously established from DFT1 biopsies obtained under the approval of the Animal Ethics Committee of the Tasmanian Parks and Wildlife Service (permit numbers A0017090 and A0017550)<sup><xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref></sup>. DFT2 cell lines RV and JV were established from single cell suspensions obtained from tumour biopsies<sup><xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-4" hwp:rel-id="ref-3">3</xref></sup>. Cells were cultured at 35 °C with 5% CO<sub>2</sub> in Gibco™ RPMI 1640 medium with L-glutamine (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (Bovogen Biologicals, Melbourne, VIC, Australia), 1% (v/v) Gibco™ Antibiotic-Antimycotic (100X) (Thermo Fisher Scientific), 10 mM Gibco™ HEPES (Thermo Fisher Scientific) and 50 μM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) (complete RPMI medium).</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><p hwp:id="p-11">List of all devil facial tumour (DFT) cell lines and treatments</p></caption><graphic xlink:href="452299v2_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></table-wrap></sec><sec id="s2b" hwp:id="sec-4"><label>2.2</label><title hwp:id="title-8">Plasmid construction</title><p hwp:id="p-12">The coding sequence for full length devil <italic toggle="yes">CIITA</italic> (XM_023497584.2) was isolated from cDNA of devil peripheral blood mononuclear cells (PBMCs) by PCR using Q5<sup>®</sup> Hotstart High-Fidelity 2X Master Mix (New England Biolabs (NEB), Ipswich, MA, USA) (see <bold>Supplementary Table 1</bold> for list of primers and reaction conditions). Sleeping Beauty (SB) transposon plasmid pSBbi-BH<sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup> (a gift from Eric Kowarz; Addgene # 60515, Cambridge, MA, USA) was digested at SfiI sites (NEB) with the addition of Antarctic Phosphatase (NEB) to prevent re-ligation. Devil <italic toggle="yes">CIITA</italic> was then cloned into SfiI-digested pSBbi-BH using NEBuilder<sup>®</sup> HiFi DNA Assembly Cloning Kit (NEB). The assembled plasmid pCO2 was transformed into NEB<sup>®</sup> 5-alpha competent <italic toggle="yes">Escherichia coli</italic> (High Efficiency) (NEB) according to manufacturer’s instructions (see <bold>Supplementary Figure 1</bold> for plasmid maps). Positive clones were identified by colony PCR and the plasmids were isolated using NucleoSpin<sup>®</sup> Plasmid EasyPure kit (Macherey-Nagel, Düren, Germany). The DNA sequence of the cloned devil <italic toggle="yes">CIITA</italic> transcript was verified by Sanger sequencing using Big Dye<sup>™</sup> Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems (ABI), Foster City, CA, USA) and Agencourt<sup>®</sup> CleanSEQ<sup>®</sup> (Beckman Coulter, Brea, CA, USA) per manufacturer’s instructions. The sequences were analyzed on 3500xL Genetic Analyzer (ABI) (see <bold>Supplementary Table 2</bold> for list of sequencing primers). For detailed step-by-step protocols for plasmid design and construction, reagent recipes, and generation of stable cell lines, see Bio-protocol # e3696<sup><xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref></sup>.</p></sec><sec id="s2c" hwp:id="sec-5"><label>2.3</label><title hwp:id="title-9">Transfection and generation of stable cell lines</title><p hwp:id="p-13">DFT1 and DFT2 cell line C5065 and JV, respectively, were transfected with plasmid pCO2 to generate stable cell lines that overexpress CIITA. DNA transfections were performed using polyethylenimine (PEI) (1 mg/mL, linear, 25 kDa; Polysciences, Warrington, FL, USA) at a 3:1 ratio of PEI to DNA (w/w) as previously described<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">8</xref></sup>. Briefly, DFT cells were co-transfected with pCO2 and SB transposase vector pCMV(CAT)T7-SB100<sup><xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref></sup> (a gift from Zsuzsanna Izsvak; Addgene plasmid # 34879) at a ratio of 3:1 in μg, respectively. One μg of total plasmid DNA was used per mL of culture volume. The cells were incubated with the transfection solution overnight at 35 °C with 5% CO<sub>2</sub>. The media was removed and replaced with fresh complete RPMI medium. 48 h post-transfection, the cells were observed for expression of reporter gene mTagBFP. Positively-transfected cells were selected with 1 mg/mL hygromycin B (Sigma-Aldrich) for seven days before being maintained in 200 μg/mL hygromycin B in complete RPMI medium. The two tumour cell lines were also transfected with empty vector pSBbi-BH as controls.</p></sec><sec id="s2d" hwp:id="sec-6"><label>2.4</label><title hwp:id="title-10">RNA sequencing and analysis</title><p hwp:id="p-14">RNA libraries were prepared, sequenced and processed as previously described<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-3" hwp:rel-id="ref-8">8</xref>,<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>,<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref></sup>. <bold><xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref></bold> shows the source of RNA samples used in this study. Briefly, RNA extraction (two replicates per cell line) was performed using the Nucleospin® RNA Plus Kit (Macherey-Nagel) following the manufacturer’s instructions. mRNA libraries were prepared and sequenced at the Ramaciotti Centre for Genomics (Sydney, NSW, Australia). All RNA samples had RNA Integrity Number (RIN) scores of 10.0. Libraries were prepared using TruSeq Stranded mRNA Library Prep (Illumina Inc., San Diego, CA, USA) and single-end, 100-base pair sequencing were performed on an Illumina NovaSeq 6000 platform (Illumina). The quality of the sequencing reads was assessed using FastQC version 0.11.9<sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref></sup>. Raw FASTQ files for DFT1.CIITA and DFT2.CIITA have been deposited to the European Nucleotide Archive (ENA) and are available at BioProject # PRJEB45867. Subread version 2.0.0<sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref></sup> was used to align sequencing reads to the Tasmanian devil reference genome (GCA_902635505.1 mSarHar1.11) and the number of reads mapped to a gene was counted using featureCounts<sup><xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref></sup>. The analysis of differentially expressed genes was performed using the statistical software R studio<sup><xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref></sup> on R version 4.0.0<sup><xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref></sup>. Genes with less than 100 aligned reads across all samples were excluded from the analysis and raw library sizes were scaled using <italic toggle="yes">calcNormFactors</italic> in edgeR<sup><xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>–<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref></sup>. To account for varying sequencing depths between lanes, read counts were normalised by upper quartile normalisation using <italic toggle="yes">betweenLaneNormalization</italic> in EDASeq<sup><xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>,<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref></sup>. Gene length-related biases were normalised by scaling read counts to transcripts per kilobase million (TPM). Differential expression analysis was carried out using the <italic toggle="yes">voom</italic><sup><xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref></sup> function in <italic toggle="yes">limma</italic><sup><xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref></sup> with linear modelling and empirical Bayes moderation<sup><xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref></sup>. To isolate differentially expressed genes, gene expression of CIITA- or NLRC5-expressing cell lines (DFT.CIITA, DFT.NLRC5) was compared against vector-only control (DFT.BFP) while IFNG-treated cells (DFT.WT + IFNG) was compared against untreated cells (DFT.WT), according to their respective tumour origin. Genes were defined as significantly differentially expressed by applying false discovery rate (FDR) &lt; 0.05, and log<sub>2</sub> fold change (FC) ≥ 2.0 (upregulated) or ≤ ∼2.0 (downregulated) thresholds (see <bold>Supplementary Table 3</bold> for list of differentially expressed genes).</p><p hwp:id="p-15">Venn diagrams of differentially expressed genes were developed using Venny version 2.1<sup><xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref></sup>. Heatmaps were created from log<sub>2</sub>(TPM) values using the ComplexHeatmap<sup><xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref></sup> package in R studio. For functional enrichment analysis, over-representation of gene ontology (GO) biological processes in the list of differentially expressed genes was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID) functional annotation tool<sup><xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>,<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref></sup>. The Tasmanian devil <italic toggle="yes">Sarcophilus harrisii</italic> was applied as the species for gene lists and background. Significant GO terms (GOTERM_BP_ALL) were selected by applying the following thresholds: p-value &lt; 0.05 and FDR &lt; 0.05. GO terms were sorted in descending order of fold enrichment values.</p><p hwp:id="p-16">To simplify the identification of devil MHC allotypes and maintain consistency in nomenclature to previous works, MHC transcripts in this manuscript were renamed according to Cheng et al., based on sequence similarity<sup><xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref></sup> (see <bold>Supplementary Table 4</bold> for corresponding NCBI gene symbols). MHC transcripts <italic toggle="yes">LOC100918485</italic> and <italic toggle="yes">LOC100918744</italic>, which have not been previously characterised, are predicted to encode beta chains of the MHC-II DA gene based on gene homology. These transcripts were renamed as <italic toggle="yes">SAHA-DAB_X1</italic> and <italic toggle="yes">SAHA-DAB_X2</italic>, respectively. Similarly, genes without an official gene symbol (LOC prefixes) were given aliases based on the gene description on NCBI.</p></sec><sec id="s2e" hwp:id="sec-7"><label>2.5</label><title hwp:id="title-11">Flow cytometric analysis of B2M and MHC-II expression</title><p hwp:id="p-17">Cultured cells were harvested using TrypLE™ Express Enzyme (1X) (Thermo Fisher Scientific) and counted using a haemocytometer. 1×10<sup>5</sup> cells per well were aliquoted into round-bottom 96-well plates and washed with 1X PBS (Thermo Fisher Scientific). Washing steps include centrifugation at 500<italic toggle="yes">g</italic> for 3 min at 4 °C to pellet cells before removal of supernatant. Cells were first stained with Invitrogen™ LIVE/DEAD™ Fixable Near-IR Dead Cell Stain kit (Thermo Fisher Scientific) diluted according to manufacturer’s instructions for 30 min on ice, protected from light. After staining, cells were washed twice with 1X PBS. For MHC-II expression, a monoclonal mouse antibody against the intracellular tail of human HLA-DR α chain was used (Clone TAL.1B5, # M0746, Agilent, Santa Clara, CA, USA). Detection of MHC-I on the surface of cells was performed using a monoclonal mouse antibody against devil beta-2-microglobulin (B2M) in supernatant (Clone 13-34-45; a gift from Hannah Siddle<sup><xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-3" hwp:rel-id="ref-5">5</xref></sup>). Cells for intracellular staining of HLA-DR were first fixed and permeabilised using BD Cytofix/Cytoperm™ Plus Fixation/Permeabilization Kit (BD Biosciences, North Ryde, NSW, Australia). All intracellular antibody staining, and washes were carried out in 1X BD Perm/Wash™ Buffer (BD Biosciences) while FACS buffer (PBS with 0.5% BSA, 0.02% sodium azide) was used for surface antibody staining. All cells were incubated with 1% normal goat serum (Thermo Fisher Scientific) for blocking, 10 min on ice. After that, cells were washed and incubated with either anti-human HLA-DRα (0.48 μg/mL) or anti-devil B2M antibody (1:250 v/v dilution) for 30 min on ice. Cells were washed once and stained with goat anti-mouse IgG-Alexa Fluor 488 (2 μg/mL, # A11029, Thermo Fisher Scientific) for 30 min on ice, in the dark. Two final washes were given to remove excess secondary antibody. Fixed cells were resuspended in FACS buffer while the rest were resuspended in FACS fix solution (0.02% sodium azide, 1.0% glucose, 0.4% formaldehyde). Analysis was carried out using Cytek™ Aurora (Cytek Biosciences, Fremont, CA, USA). As a positive control for MHC-I expression, DFT cells were treated with 10 ng/mL devil recombinant IFNG<sup><xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref></sup> for 24 h.</p></sec><sec id="s2f" hwp:id="sec-8"><label>2.6</label><title hwp:id="title-12">Protein extraction and western blot</title><p hwp:id="p-18">Cells were harvested and centrifuged at 500<italic toggle="yes">g</italic> for 5 min at room temperature. The pellet was washed twice with cold 1X PBS and weighed. Total cell protein was extracted by adding 1 mL RIPA Lysis and Extraction Buffer (Thermo Fisher Scientific), 10 μL Halt™ Protease Inhibitor Cocktail (Thermo Fisher Scientific) and 10 μL Halt™ Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific) per 40 mg of wet cell pellet. The suspension was sonicated for 30 seconds with 50% pulse and then mixed gently for 15 min on ice. The mixture was centrifuged at 14000<italic toggle="yes">g</italic> for 15 min to pellet the cell debris. The supernatant was transferred to a new tube and total protein was quantified using EZQ® Protein Quantitation kit (Invitrogen) according to manufacturer’s instructions. Two replicates per cell line were prepared for protein extraction. 20 μg of protein per sample was used for target protein detection by western blot. Protein samples were subjected to SDS-PAGE using Bolt™ 4-12%, Bis-Tris, 1.0 mm Mini Protein Gel (Thermo Fisher Scientific). Briefly, protein samples were treated with 1X Bolt™ LDS Sample Buffer (Thermo Fisher Scientific) and 1X Bolt™ Reducing Agent (Thermo Fisher Scientific) at 70 °C for 10 min. Samples were loaded onto the gel and run with 1X Bolt™ MES SDS Running Buffer (Thermo Fisher Scientific) in the Mini Gel Tank (Thermo Fisher Scientific) at 100 V for 5 min followed by 200 V for 15 min. SeeBlue™ Plus2 Pre-stained Protein Standard (Thermo Fisher Scientific) was used as a molecular weight marker. Proteins were transferred to a nitrocellulose membrane using iBlot™ Transfer Stack, nitrocellulose, mini (Thermo Fisher Scientific) and iBlot™ Gel Transfer Device (Thermo Fisher Scientific) using the following settings: 20 V for 7.5 min.</p><p hwp:id="p-19">For immunodetection, the membrane was blocked with TBSTM (Tris-buffered saline (TBS): 50 mM Tris-HCl, 150 mM NaCl, pH 7.6), 0.05% Tween 20, and 5% skim milk) for 1 hour at room temperature and rinsed twice with TBST (TBS, 0.05% Tween 20). Then, the membrane was incubated with: (i) rabbit polyclonal anti-beta actin antibody (# ab8227, Abcam, Cambridge, UK) diluted in TBSTM (400 ng/mL), (ii) mouse monoclonal anti-devil SAHA-UA/UB/UC in supernatant (Clone 15-25-18; a gift from Hannah Siddle<sup><xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref></sup>), or (iii) mouse monoclonal anti-devil SAHA-UK in supernatant (Clone 15-29-1; a gift from Hannah Siddle<sup><xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-3" hwp:rel-id="ref-10">10</xref></sup>) overnight at 4 °C. The membranes were washed four times with TBST for a duration of 5 min each wash. After that, the membranes were incubated with either HRP-conjugated goat anti-mouse (250 ng/mL; # P0447, Agilent) or HRP-conjugated goat anti-rabbit immunoglobulin (62.5 ng/mL; # P0448, Agilent) diluted in TBSTM for 1 hour at room temperature. The membranes were given final washes as described above. All incubation and washing steps were performed under agitation. Target protein expression was detected using Immobilon™ Western Chemiluminescent HRP Substrate (Merck Millipore, Burlington, MA, USA) according to manufacturer’s protocol. Protein bands were visualised using Amersham™ Imager 600 (GE Healthcare Life Sciences, Malborough, MA, USA).</p></sec><sec id="s2g" hwp:id="sec-9"><label>2.7</label><title hwp:id="title-13">Flow cytometric analysis of serum antibody binding</title><p hwp:id="p-20">Serum samples from four devils (My, TD4, TD5, and TD6), collected before (pre-immune) and after DFT1 clinical manifestations (immune), were used to assess antibody responses towards CIITA-expressing DFT cell lines (<bold>Supplementary Table 5</bold>). The serum samples were identified as immune from the presence of anti-DFT1 antibodies, which were found to be predominantly against MHC-I on DFT1 cells<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-4" hwp:rel-id="ref-8">8</xref></sup>. ‘My’ was a devil that was immunised, challenged with DFT1 cells, and subsequently treated with an experimental immunotherapy that induced tumour regression<sup><xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-3" hwp:rel-id="ref-9">9</xref></sup>. TD4, TD5, and TD6 were naturally DFT1-infected wild devils with either spontaneous tumour regressions (TD4); MHC-II<sup>+</sup> and CD3<sup>+</sup> tumour-infiltrating lymphocytes in the tumour (TD5); or B2M<sup>+</sup> DFT1 cells in fine needle aspirations of a tumour (TD6)<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref></sup>. A devil with no clinical signs of DFTD during serum collection (TD7) was included as a negative control for antibody binding towards the DFT cell lines.</p><p hwp:id="p-21">Cells were harvested and aliquoted into round-bottom 96-well plates as indicated above. After washing with PBS, cells were stained with LIVE/DEAD™ Fixable Near-IR Dead Cell Stain for 30 min on ice and washed twice with PBS. For blocking, cells were incubated with 1% normal goat serum for 10 min and washed once with FACS buffer. Serum samples were thawed on ice and diluted with FACS buffer (1:50 v/v). 50 μL of serum was added to cells for 1 h and then washed. After that, cells were stained with 10 μg/mL monoclonal mouse anti-devil IgG antibody (A4-D1-2-1, provided by WEHI)<sup><xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref></sup> diluted in FACS buffer for 30 min. The cells were washed and stained with 2 μg/mL goat anti-mouse IgG-Alexa Fluor 647 (# A21235, Thermo Fisher Scientific) in FACS buffer for 30 min. After washing, cells were fixed in FACS fix solution and analysed on Cytek™ Aurora. All washing steps include two washes with FACS buffer unless indicated otherwise and all staining steps were carried out on ice, protected from light.</p></sec></sec><sec id="s3" hwp:id="sec-10"><label>3.</label><title hwp:id="title-14">Results</title><sec id="s3a" hwp:id="sec-11"><label>3.1</label><title hwp:id="title-15">CIITA plays a dominant role in antigen presentation</title><p hwp:id="p-22">To delineate the role of CIITA in DFT cells, differentially expressed genes following stable expression of CIITA were analysed by gene ontology (GO) functional enrichment analysis. Differential expression analysis revealed 888 genes, excluding CIITA, that were modulated (|log<sub>2</sub>FC| ≥ 2, FDR &lt; 0.05) in DFT1.CIITA compared to vector-only cell line DFT1.BFP (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1</xref></bold>, <bold>Supplementary Table 3</bold>). In DFT2.CIITA, there were 56 genes that were differentially expressed relative to DFT2.BFP. Ten genes were commonly up- or down-regulated by CIITA in DFT1 and DFT2 cells. Most of these genes were of the MHC-II antigen processing and presentation pathway. <italic toggle="yes">SAHA-DAA, SAHA-DAB2</italic> and <italic toggle="yes">SAHA-DAB3</italic> are devil classical MHC-II genes while <italic toggle="yes">SAHA-DMA</italic> and <italic toggle="yes">SAHA-DMB</italic> encode non-classical MHC-II. Others include <italic toggle="yes">CD74</italic> and gamma-interferon-inducible lysosomal thiol reductase (<italic toggle="yes">IFI30</italic>), which encode the invariant chain, an MHC-II chaperone, and an enzyme for lysosomal degradation of proteins, respectively. Except for <italic toggle="yes">IFI30</italic>, these genes were among the most highly upregulated genes in the transcriptome of DFT1.CIITA (<bold><xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref></bold>) and DFT2.CIITA (<bold><xref ref-type="table" rid="tbl3" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Table 3</xref></bold>).</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1.</label><caption hwp:id="caption-2"><p hwp:id="p-23">Venn diagram of differentially expressed genes in DFT1 and DFT2 cells with CIITA overexpression. Change in gene expression was identified between DFT.CIITA and vector-only control DFT.BFP. Total number of DEGs is indicated in parenthesis under sample name and the number of upregulated (↑) and downregulated genes (↓) are described in each Venn circle. Mutually inclusive genes that were upregulated are indicated in black and downregulated in red.</p></caption><graphic xlink:href="452299v2_fig1" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-3"><p hwp:id="p-24">Top 20 most significantly upregulated genes in DFT1.CIITA</p></caption><graphic xlink:href="452299v2_tbl2" position="float" orientation="portrait" hwp:id="graphic-3"/></table-wrap><table-wrap id="tbl3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/TBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tbl3</object-id><label>Table 3.</label><caption hwp:id="caption-4"><p hwp:id="p-25">Significantly upregulated genes in DFT2.CIITA</p></caption><graphic xlink:href="452299v2_tbl3" position="float" orientation="portrait" hwp:id="graphic-4"/></table-wrap><p hwp:id="p-26">In DFT1.CIITA, several MHC-I heavy chain and accessory genes were strongly induced, depicting a role of CIITA in MHC-I antigen presentation (<bold><xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2">Table 2</xref></bold>). These include: (i) MHC-I heavy alpha chain genes <italic toggle="yes">SAHA-UA, SAHA-UB</italic>, and <italic toggle="yes">SAHA-UC</italic>; and (ii) <italic toggle="yes">B2M</italic>, which associates with MHC-I alpha chains to form the trimeric structure of MHC-I molecules; (iii) transporter associated with antigen processing 1 (<italic toggle="yes">TAP1</italic>) for peptide transport into the endoplasmic reticulum; and (iv) proteasomal subunits <italic toggle="yes">PSMB8</italic> and <italic toggle="yes">PSMB9</italic>.</p><p hwp:id="p-27">Next, all significantly up- or down-regulated genes were analysed for enriched GO biological processes using DAVID bioinformatics resource. Thresholds <italic toggle="yes">p</italic> value &lt; 0.05 and FDR &lt; 0.05 were applied to filter out insignificant over-represented GO terms. The most significantly enriched GO biological process in the list of upregulated genes in DFT1.CIITA and DFT2.CIITA was <italic toggle="yes">antigen processing and presentation</italic> (GO:0019882) followed by <italic toggle="yes">immune response</italic> (GO:0006955) (<bold><xref ref-type="table" rid="tbl4" hwp:id="xref-table-wrap-4-1" hwp:rel-id="T4">Table 4</xref></bold>). Both processes were identified in genes of the MHC-I and MHC-II machinery (<bold>Supplementary Tables 6</bold> and <bold>7</bold>). C<italic toggle="yes">ell adhesion</italic> (GO:0007155) and <italic toggle="yes">cell communication</italic> (GO:0007154) were enriched in genes downregulated in DFT1.CIITA; there were no GO biological processes that were associated with downregulated genes in DFT2.CIITA.</p><table-wrap id="tbl4" orientation="portrait" position="float" hwp:id="T4" hwp:rev-id="xref-table-wrap-4-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/TBL4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tbl4</object-id><label>Table 4.</label><caption hwp:id="caption-5"><p hwp:id="p-28">GO biological processes enriched in differentially expressed genes in DFT1.CIITA and DFT2.CIITA</p></caption><graphic xlink:href="452299v2_tbl4" position="float" orientation="portrait" hwp:id="graphic-5"/></table-wrap></sec><sec id="s3b" hwp:id="sec-12"><label>3.2</label><title hwp:id="title-16">Regulation of MHC-I and MHC-II pathway by CIITA</title><p hwp:id="p-29">To further characterise the regulation of MHC-I and MHC-II by CIITA and how it differs from IFNG or NLRC5 stimulation, a heatmap was used to display the relative expression of MHC-I and MHC-II genes, and key accessory proteins between the different treatments. The transcriptome of IFNG-treated DFT2 cells was previously carried out on DFT2 cell line RV (DFT2.WT<sup>RV</sup>)<sup><xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">27</xref></sup> while subsequent experiments on DFT2 cells were performed using DFT2 cell line JV (DFT2.WT). Schwann cell differentiation marker SRY-box 10 (<italic toggle="yes">SOX10</italic>) and neuroepithelial marker nestin (<italic toggle="yes">NES</italic>) were used as internal gene controls, and myelin protein periaxin (<italic toggle="yes">PRX</italic>) was used to discriminate DFT1 cells from DFT2.</p><p hwp:id="p-30">As described above, CIITA induced the transcription of <italic toggle="yes">B2M;</italic> MHC-I heavy chains <italic toggle="yes">SAHA-UA, -UB, -UC</italic>; <italic toggle="yes">PSBM8; PSMB9;</italic> and <italic toggle="yes">TAP1</italic> in DFT1 cells. There was also an upregulation of non-classical MHC-I <italic toggle="yes">SAHA-UK</italic>, and downregulation of <italic toggle="yes">NLRC5</italic> and proteasomal subunit <italic toggle="yes">PSBM10</italic> in DFT1.CIITA cells (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2</xref></bold>). Excluding <italic toggle="yes">NLRC5</italic>, genes that were modulated in DFT1.CIITA were synonymously up- or down-regulated in DFT1.NLRC5, suggesting similar roles of CIITA to NLRC5 in DFT1 cells. However, induction of the MHC-I pathway by CIITA was not as strong as NLRC5 despite having similarly high levels of expression in the respective cell lines (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2</xref></bold>, <bold>Supplementary Table 3</bold>). IFNG exhibited a wider range in regulation of genes from the MHC-I pathway compared to NLRC5 and CIITA. Peptide transporter <italic toggle="yes">TAP2</italic> and MHC-I chaperone TAP binding protein (<italic toggle="yes">TAPBP</italic>) were exclusively upregulated by IFNG in DFT1 and DFT2 cells. Meanwhile, the expression of CIITA in DFT2 cells did not appear to significantly influence any of the MHC-I machinery.</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2.</label><caption hwp:id="caption-6"><p hwp:id="p-31">Heatmap showing relative expression of genes involved in MHC-I and MHC-II antigen processing and presentation in wild type, IFNG-treated, BFP- (vector control), NLRC5-, and CIITA-expressing DFT1 and DFT2 cells. Z-scores were calculated from log<sub>2</sub>TPM expression values and scaled across each gene (rows). High and low relative expression are represented by red and blue, respectively. Replicates per treatment (<italic toggle="yes">N</italic>=2) are included in the heatmap.</p></caption><graphic xlink:href="452299v2_fig2" position="float" orientation="portrait" hwp:id="graphic-6"/></fig><p hwp:id="p-32">High levels of CIITA transcripts in DFT1.CIITA was correlated with strong induction of all the MHC-II genes, with <italic toggle="yes">SAHA-DAB_X1</italic> and <italic toggle="yes">SAHA-DAB_X2</italic> being the weakest. This was not observed in the other cell lines nor in DFT2.CIITA. CIITA was expressed to a lesser extent in DFT2.CIITA relative to DFT1.CIITA, and all MHC-II genes but <italic toggle="yes">SAHA-DAB_X1</italic> and <italic toggle="yes">SAHA-DAB_X2</italic> were upregulated. The expression of <italic toggle="yes">CIITA</italic>, MHC-II genes and <italic toggle="yes">CD74</italic> was relatively low in DFT1.WT and DFT2.WT cells except for <italic toggle="yes">SAHA-DAB2</italic> and <italic toggle="yes">SAHA-DAB3</italic> in DFT1.WT. There was a moderate increase in CIITA expression after IFNG treatment in DFT1 cells, but it was insufficient to initiate transcription of MHC-II genes or <italic toggle="yes">CD74</italic>. In IFNG-treated DFT2 cells where CIITA was induced to a higher degree, there was only partial activation of the MHC-II gene set (<italic toggle="yes">SAHA-DAA, SAHA-DMA, SAHA-DMB</italic>), and an upregulation of <italic toggle="yes">CD74</italic>. Interestingly, MHC-II protease cathepsin <italic toggle="yes">CTSS</italic> was only induced with IFNG treatment in DFT1 and DFT2 cells.</p></sec><sec id="s3c" hwp:id="sec-13"><label>3.3</label><title hwp:id="title-17">MHC-I and MHC-II molecules are upregulated by CIITA in DFT cells</title><p hwp:id="p-33">MHC-II (HLA-DRA) protein expression was absent in wild type (WT) DFT1 and DFT2 cells and in vector-only transfected cells (BFP) but was significantly upregulated in CIITA-expressing DFT1 cells (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3A</xref></bold>). In DFT2 cells, the overexpression of CIITA did not alter median MHC-II expression, or more specifically MHC-II gene loci HLA-DRA. Neither IFNG treatment nor NLRC5 overexpression induced MHC-II protein expression in DFT1 and DFT2 cells. CIITA was capable of restoring surface expression of B2M in DFT1 cells, albeit to a lesser degree than NLRC5 and IFNG stimulation, consistent with the transcriptomic results (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Figure 3A</xref>, <xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2</xref></bold>). Meanwhile the basal expression of B2M in DFT2 cells was enhanced slightly by CIITA.</p><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3.</label><caption hwp:id="caption-7"><p hwp:id="p-34">Expression of MHC-II, B2M and MHC-I in DFT1 and DFT2 cell lines. (<bold>A</bold>) Wild type (WT), IFNG-treated (IFNG), vector-only control (BFP), NLRC5-overexpressing (NLRC5) or CIITA-overexpressing (CIITA) DFT1 and DFT2 cells were analysed by flow cytometry for B2M and MHC-II expression using antibodies against surface devil B2M or intracellular HLA-DR alpha chain (HLA-DRA), respectively (<italic toggle="yes">solid line</italic>). B2M and MHC-II expressions were overlaid with a secondary antibody-only control (<italic toggle="yes">shaded area</italic>). The results shown are representative of <italic toggle="yes">N</italic>=3 replicates/treatment. (<bold>B</bold>) Cell lysate from devil fibroblast, DFT1 and DFT2 cell lines was incubated with an antibody against MHC-I heavy chain genes SAHA-UA/UB/UC for western blot analysis of MHC-I expression. β-actin was included as a loading control. <italic toggle="yes">MW</italic>, molecular weight.</p></caption><graphic xlink:href="452299v2_fig3" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><p hwp:id="p-35">In agreement with an increase in surface B2M expression on DFT1.CIITA by flow cytometry, an upregulation of MHC-I heavy chains was detected by western blot compared to wild type (DFT1.WT) and vector-only cells (DFT1.BFP) (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Figure 3B</xref></bold>). IFNG-treated and NLRC5-overexpressing DFT1 and DFT2 cells also expressed elevated levels of MHC-I heavy chains. Although flow cytometry detected an increase in B2M expression on DFT2.CIITA, the expression of MHC-I heavy chains by western blot was similar to DFT2.WT and DFT2.BFP.</p></sec><sec id="s3d" hwp:id="sec-14"><label>3.4</label><title hwp:id="title-18">Analysis of anti-DFT serum antibody response against CIITA-induced antigens</title><p hwp:id="p-36">We have previously shown that MHC-I on DFT1 cells is the predominant antibody target in devils with natural and induced anti-DFT immune response including tumour regressions<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-5" hwp:rel-id="ref-8">8</xref></sup>. Here we tested if expression of CIITA in DFT cells could also upregulate antibody targets on DFT cells. Four devils (My, TD4, TD5, TD6) that developed DFT1 tumours and subsequent serum antibodies (immune) that bound MHC-I were selected for screening against CIITA-expressing DFT1 and DFT2 cells. Serum from each devil prior to DFT1 infection or observable DFT1 tumours (pre-immune) was included to assess the change in antibody levels after DFT1 infection.</p><p hwp:id="p-37">Relative to MHC-I negative DFT1.WT and DFT1.BFP, serum antibodies from all four devils post-DFT1 development generally showed higher binding to DFT1 cells overexpressing NLRC5 (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Figure 4</xref></bold>). Antibody levels against CIITA-expressing DFT1 cells were higher than DFT1.WT and DFT1.BFP in immune sera from My, a captive devil with an immunotherapy-induced DFT1 regression, and TD4, a wild devil with a natural DFT1 regression. Binding of serum antibodies to DFT1.CIITA cells was relatively lower than DFT1.NLRC5. There was no increase in antibody binding towards DFT1.CIITA compared to DFT1.WT and DFT1.BFP from immune sera of devils TD5 and TD6.</p><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.14.452299v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4.</label><caption hwp:id="caption-8"><p hwp:id="p-38">Flow cytometric analysis of serum antibody response towards DFT1 and DFT2 cells overexpressing CIITA. Sera from four devils (My, TD4, TD5, TD6) with antibody responses to MHC-I<sup>+</sup> DFT1 cells after DFT1 infection (immune) were used. Antibody binding was compared against wild type (DFT.WT), vector-only (DFT.BFP) and NLRC5-overexpressing cells (DFT.NLRC5). Serum collected prior to infection (pre-immune) and from a non-infected devil (TD7) were included as negative controls. <italic toggle="yes">AF647</italic>, Alexa Fluor 647.</p></caption><graphic xlink:href="452299v2_fig4" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><p hwp:id="p-39">Serum from DFT1-infected devils reacted with DFT2 cells but only following NLRC5 overexpression. Serum from My, TD4, TD5 and TD6 all had strong antibody binding to DFT2.NLRC5 which was not observed in the other DFT2 cell lines. This suggests that NLRC5 upregulates similar antigenic target(s) in DFT1 and DFT2 cells.</p></sec></sec><sec id="s4" hwp:id="sec-15"><label>4.</label><title hwp:id="title-19">Discussion</title><p hwp:id="p-40">Clonally transmissible cancers in nature are rare, and yet the Tasmanian devils are affected by two of the only three known naturally occurring transmissible cancers in vertebrates. In a cancer where allogeneity exists between individual host tissues and tumour, allogeneic MHC molecules on tumour cells are important targets for anti-tumour immunity. MHC-I expression on DFT1 cells has been exploited for vaccine development and immunotherapy to enhance anti-DFT immunity via CD8<sup>+</sup> T cell responses<sup><xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-4" hwp:rel-id="ref-9">9</xref></sup>. In this study, we showed that the class II transactivator CIITA can modulate MHC-I and MHC-II antigen processing and presentation pathways in DFT cells. Surprisingly, the overexpression of CIITA resulted in upregulation of MHC-I and MHC-II molecules in DFT1 cells but not DFT2 cells.</p><p hwp:id="p-41">MHC-II expression is normally confined to a subset of haematopoietic antigen-presenting cells, and DFT1 and DFT2 cells do not typically express MHC-II genes and proteins. We demonstrated the expression of MHC-II proteins in non-haematopoietic DFT1 cells through CIITA-induced upregulation of classical and non-classical MHC-II genes, and the invariant chain <italic toggle="yes">CD74</italic>. The lack of detectable MHC-II proteins in CIITA-expressing DFT2 cells could be due to insufficient expression of MHC-II genes and <italic toggle="yes">CD74</italic> for stable expression of MHC-II molecules. Post-transcriptional regulation might be involved in MHC-II expression in DFT cells, as described in human T cells<sup><xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref></sup>. However, the regulation of MHC-II expression by CIITA in a quantitative (and qualitative) manner, in which CIITA is the rate-determining factor for mRNA and protein expression of MHC-II genes<sup><xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref></sup>, suggests a correlation between lack of MHC-II protein expression and the relatively low CIITA expression in DFT2.CIITA compared to DFT1.CIITA. A heterozygous non-synonymous mutation (D59N) in transcription factor <italic toggle="yes">RFX5</italic> is present in DFT2 tumours<sup><xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">6</xref></sup>. RFX5 is a transcription factor of the multiprotein MHC enhanceosome that regulates MHC-I and MHC-II expression<sup><xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref>,<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">51</xref></sup>. Although transcription of MHC-I and MHC-II genes were inducible in DFT2 cells following stimulation, the functional impact of this mutation on MHC transcription remains to be explored.</p><p hwp:id="p-42">Differential expression of MHC-II allotypes upon CIITA induction, as observed with <italic toggle="yes">SAHA-DAB_X1</italic> and <italic toggle="yes">SAHA-DAB_X2</italic> that were consistently expressed at lower levels compared to other MHC-II genes, suggests additional regulatory mechanism(s) that control the expression of MHC-II genes beyond that of CIITA. Variations in expression levels of MHC-I and MHC-II genes have been associated with sequence polymorphism in the promoter or 3’ untranslated region (UTR) of MHC genes, which modulates transcription either epigenetically or non-epigenetically, in addition to post-transcriptional regulation<sup><xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">52</xref>–<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">54</xref></sup>. The varying degrees of inducibility and expression of devil MHC-II allotypes could correlate to tissue-specific expression, with functions that differ from classical MHC-II genes.</p><p hwp:id="p-43">Consistent with findings from pioneering studies on CIITA function<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-2" hwp:rel-id="ref-20">20</xref>,<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21">21</xref></sup>, CIITA exhibited transcriptional activity over the MHC-I pathway in DFT1 cells that lack MHC-I expression. The ability of CIITA to regulate MHC-I expression is attributed to similarities in the regulatory elements at the proximal promoters of MHC-I and MHC-II genes, and interaction with the same transcription factors of the MHC enhanceosome as NLRC5<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-3" hwp:rel-id="ref-20">20</xref>,<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-3" hwp:rel-id="ref-21">21</xref>,<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-2" hwp:rel-id="ref-51">51</xref>,<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">55</xref>,<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">56</xref></sup>. In MHC-I positive DFT2 cells, overexpression of CIITA resulted in minimal upregulation of MHC-I compared with NLRC5 or IFNG stimulation. The limited CIITA influence on MHC-I expression is commonly observed in cells with high constitutive levels of MHC-I<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-4" hwp:rel-id="ref-20">20</xref>,<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-4" hwp:rel-id="ref-21">21</xref></sup>. This illustrates the role of NLRC5 as the primary transactivator for MHC-I expression and a secondary role for CIITA.</p><p hwp:id="p-44">Unlike the ubiquitous expression of MHC-I molecules in nucleated cells, MHC-II expression is tightly regulated in a cell type-, differentiation-, and stimulus-specific manner. Evidence for inducibility of MHC-II expression in DFT cells suggests that MHC-II-restricted tumour antigen presentation could occur in the physiological setting under inflammatory conditions that upregulate CIITA. This could provide additional targets for allogeneic antibody responses, as our results show that CIITA upregulation increases binding of serum antibodies collected from devils that had both natural and immunotherapy-induced DFT1 regressions. In canine transmissible venereal tumour (CTVT), the tumour regression phase is often associated with upregulation of MHC-I and MHC-II molecules, mediated by factors such as IFNG from tumour infiltrating lymphocytes<sup><xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">57</xref>,<xref ref-type="bibr" rid="c58" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">58</xref></sup>.</p><p hwp:id="p-45">The capacity to express MHC-II molecules with CIITA expression could stem from the Schwann cell origins of DFT1 and DFT2 cells<sup><xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-3" hwp:rel-id="ref-27">27</xref>,<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">59</xref></sup>. Schwann cells express MHC-II molecules upon traumatic and inflammatory injury, playing a role in antigen presentation to CD4<sup>+</sup> T cells to modulate local immune responses<sup><xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">60</xref>,<xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">61</xref></sup>. Similarly, CIITA-expressing DFT cells have the potential to present MHC-II-restricted tumour antigens to CD4<sup>+</sup> T cells and potentiate anti-DFT immune responses. Several studies in murine models have demonstrated immune-mediated tumour rejection and/or tumour growth retardation using MHC-II-expressing tumour cell lines, either through CIITA or MHC-II gene transfer<sup><xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">62</xref>–<xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">67</xref></sup>. These primary responses were also protective against subsequent challenge with parental MHC-II negative tumours. The expression of MHC-II on CIITA-expressing DFT cells can offer insight into the importance of CD4<sup>+</sup> T cells in the interplay with other immune cells for anti-tumour immunity and allograft rejection.</p><p hwp:id="p-46">In this study, the role of CIITA as the master regulator of MHC-II expression was reaffirmed in a non-model immunology research species. We have delineated the regulation of MHC-I and MHC-II pathways by CIITA in marsupials and transmissible cancers. The ability to induce MHC-II expression in transmissible tumour cells creates an avenue for vaccine and immunotherapeutic strategies to enhance anti-tumour immunity through CD4<sup>+</sup> T cell help and inform of the importance of MHC-II in anti-tumour and allogeneic immune responses. The relatively simple process we developed for making cell lines that constitutively express NLRC5 and CIITA can be readily adapted for many other species and potentially be used in conjunction with CD80/CD86 to provide antigen stimulation in <italic toggle="yes">in vitro</italic> assays. This is critical for 99% of species that lack reagents, such as agonistic anti-CD3 and anti-CD28 antibodies, for inducing T cell activation <italic toggle="yes">in vitro</italic>.</p></sec><sec sec-type="supplementary-material" hwp:id="sec-16"><title hwp:id="title-20">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supplementary Materials</label><media xlink:href="supplements/452299_file02.pdf" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC2"><object-id pub-id-type="other" hwp:sub-type="slug">DC2</object-id><label>Supplementary Table 3</label><media xlink:href="supplements/452299_file03.xlsx" position="float" orientation="portrait" hwp:id="media-2"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC3"><object-id pub-id-type="other" hwp:sub-type="slug">DC3</object-id><label>Supplementary Table 6</label><media xlink:href="supplements/452299_file04.xlsx" position="float" orientation="portrait" hwp:id="media-3"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC4"><object-id pub-id-type="other" hwp:sub-type="slug">DC4</object-id><label>Supplementary Table 7</label><media xlink:href="supplements/452299_file05.xlsx" position="float" orientation="portrait" hwp:id="media-4"/></supplementary-material></sec></body><back><sec id="s5" hwp:id="sec-17"><title hwp:id="title-21">Declaration of competing interest</title><p hwp:id="p-47">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec id="s6" hwp:id="sec-18"><title hwp:id="title-22">Funding</title><p hwp:id="p-48">This work was supported by the Australian Research Council (ARC) DECRA grant # DE180100484 and ARC Discovery grant # DP180100520, University of Tasmania Foundation Dr. Eric Guiler Tasmanian Devil Research Grant through funds raised by the Save the Tasmanian Devil Appeal (2013, 2015, 2017).</p></sec><sec id="s7" hwp:id="sec-19"><title hwp:id="title-23">Authors’ contributions</title><p hwp:id="p-49">ABL, ASF, CEBO and GMW designed the study. ASF and CEBO developed the technology. CEBO performed the experiments and bioinformatic analyses. CEBO created the figures. ABL, ASF, CEBO, GMW, HVS and YC analysed and interpreted the data. CEBO wrote the manuscript, and all authors edited the manuscript.</p></sec><ack hwp:id="ack-1"><title hwp:id="title-24">Acknowledgements</title><p hwp:id="p-50">The authors would like to thank Jocelyn Darby and Alana De Luca for assistance in the lab, Terry Pinfold for assistance in flow cytometry, and Amanda Patchett for assistance in bioinformatic analysis. We wish to thank G. Ralph for ongoing care of Tasmanian devils, the Bonorong Wildlife Sanctuary for providing access to Tasmanian devils, and R. Pye for providing care for devils and collecting blood samples.</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-25">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Cunningham CX"><surname>Cunningham</surname> <given-names>CX</given-names></string-name>, <string-name name-style="western" hwp:sortable="Comte S"><surname>Comte</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="McCallum H"><surname>McCallum</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamilton DG"><surname>Hamilton</surname> <given-names>DG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamede R"><surname>Hamede</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Storfer A"><surname>Storfer</surname> <given-names>A</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-2">Quantifying 25 years of disease-caused declines in Tasmanian devil populations: host density drives spatial pathogen spread</article-title>. <source hwp:id="source-1">Ecol Lett</source> <year>2021</year>; <volume>24</volume>: <fpage>958</fpage>–<lpage>969</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1 xref-ref-2-2"><label>2</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Pearse A-M"><surname>Pearse</surname> <given-names>A-M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Swift K."><surname>Swift</surname> <given-names>K.</given-names></string-name> <article-title hwp:id="article-title-3">Allograft theory: Transmission of devil facial-tumour disease</article-title>. <source hwp:id="source-2">Nature</source> <year>2006</year>; <volume>439</volume>: <fpage>549</fpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2 xref-ref-3-3 xref-ref-3-4"><label>3</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Pye RJ"><surname>Pye</surname> <given-names>RJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pemberton D"><surname>Pemberton</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tovar C"><surname>Tovar</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tubio JMC"><surname>Tubio</surname> <given-names>JMC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dun KA"><surname>Dun</surname> <given-names>KA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fox S"><surname>Fox</surname> <given-names>S</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-4">A second transmissible cancer in Tasmanian devils</article-title>. <source hwp:id="source-3">Proc Natl Acad Sci U S A</source> <year>2016</year>; <volume>113</volume>: <fpage>374</fpage>–<lpage>379</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Siddle H V"><surname>Siddle</surname> <given-names>H V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kreiss A"><surname>Kreiss</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eldridge MDB"><surname>Eldridge</surname> <given-names>MDB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Noonan E"><surname>Noonan</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clarke CJ"><surname>Clarke</surname> <given-names>CJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pyecroft S"><surname>Pyecroft</surname> <given-names>S</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-5">Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial</article-title>. <source hwp:id="source-4">Proc Natl Acad Sci U S A</source> <year>2007</year>; <volume>104</volume>: <fpage>16221</fpage>–<lpage>6</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1 xref-ref-5-2 xref-ref-5-3"><label>5</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Siddle H V"><surname>Siddle</surname> <given-names>H V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kreiss A"><surname>Kreiss</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tovar C"><surname>Tovar</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yuen CK"><surname>Yuen</surname> <given-names>CK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cheng Y"><surname>Cheng</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Belov K"><surname>Belov</surname> <given-names>K</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-6">Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer</article-title>. <source hwp:id="source-5">Proc Natl Acad Sci U S A</source> <year>2013</year>; <volume>110</volume>: <fpage>5103</fpage>–<lpage>5108</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2"><label>6</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Stammnitz MR"><surname>Stammnitz</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coorens THH"><surname>Coorens</surname> <given-names>THH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gori KC"><surname>Gori</surname> <given-names>KC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hayes D"><surname>Hayes</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fu B"><surname>Fu</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang J"><surname>Wang</surname> <given-names>J</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-7">The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils</article-title>. <source hwp:id="source-6">Cancer Cell</source> <year>2018</year>; <volume>33</volume>: <fpage>607</fpage>–<lpage>619</lpage>.e15.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><label>7</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Pye R"><surname>Pye</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamede R"><surname>Hamede</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Siddle H V."><surname>Siddle</surname> <given-names>H V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caldwell A"><surname>Caldwell</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knowles GW"><surname>Knowles</surname> <given-names>GW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Swift K"><surname>Swift</surname> <given-names>K</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-8">Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils</article-title>. <source hwp:id="source-7">Biol Lett</source> <year>2016</year>; <volume>12</volume>: <fpage>20160553</fpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2 xref-ref-8-3 xref-ref-8-4 xref-ref-8-5"><label>8</label><citation publication-type="other" citation-type="journal" ref:id="2021.07.14.452299v2.8" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Ong CEB"><surname>Ong</surname> <given-names>CEB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patchett AL"><surname>Patchett</surname> <given-names>AL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Darby JM"><surname>Darby</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen J"><surname>Chen</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu G-S"><surname>Liu</surname> <given-names>G-S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lyons AB"><surname>Lyons</surname> <given-names>AB</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-9">NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers</article-title>. <source hwp:id="source-8">J Cancer Res Clin Oncol</source> <year>2021</year>; : <fpage>1</fpage>–<lpage>19</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1 xref-ref-9-2 xref-ref-9-3 xref-ref-9-4"><label>9</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Tovar C"><surname>Tovar</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pye RJ"><surname>Pye</surname> <given-names>RJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kreiss A"><surname>Kreiss</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cheng Y"><surname>Cheng</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brown GK"><surname>Brown</surname> <given-names>GK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Darby J"><surname>Darby</surname> <given-names>J</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils</article-title>. <source hwp:id="source-9">Sci Rep</source> <year>2017</year>; <volume>7</volume>: <fpage>43827</fpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2 xref-ref-10-3"><label>10</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Caldwell A"><surname>Caldwell</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coleby R"><surname>Coleby</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tovar C"><surname>Tovar</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stammnitz MR"><surname>Stammnitz</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kwon YM"><surname>Kwon</surname> <given-names>YM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Owen RS"><surname>Owen</surname> <given-names>RS</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-11">The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer</article-title>. <source hwp:id="source-10">Elife</source> <year>2018</year>; <volume>7</volume>: <fpage>e35314</fpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Hung K"><surname>Hung</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hayashi R"><surname>Hayashi</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lafond-Walker A"><surname>Lafond-Walker</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lowenstein C"><surname>Lowenstein</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pardoll D"><surname>Pardoll</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Levitsky H."><surname>Levitsky</surname> <given-names>H.</given-names></string-name> <article-title hwp:id="article-title-12">The central role of CD4+ T cells in the antitumor immune response</article-title>. <source hwp:id="source-11">J Exp Med</source> <year>1998</year>; <volume>188</volume>: <fpage>2357</fpage>–<lpage>2368</lpage>.</citation></ref><ref id="c12" hwp:id="ref-12"><label>12</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Janssen EM"><surname>Janssen</surname> <given-names>EM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lemmens EE"><surname>Lemmens</surname> <given-names>EE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wolfe T"><surname>Wolfe</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Christen U"><surname>Christen</surname> <given-names>U</given-names></string-name>, <string-name name-style="western" hwp:sortable="Von Herrath MG"><surname>Von Herrath</surname> <given-names>MG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schoenberger SP"><surname>Schoenberger</surname> <given-names>SP</given-names></string-name>. <article-title hwp:id="article-title-13">CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes</article-title>. <source hwp:id="source-12">Nature</source> <year>2003</year>; <volume>421</volume>: <fpage>852</fpage>–<lpage>856</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13"><label>13</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Kumamoto Y"><surname>Kumamoto</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mattei LM"><surname>Mattei</surname> <given-names>LM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sellers S"><surname>Sellers</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Payne GW"><surname>Payne</surname> <given-names>GW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Iwasaki A."><surname>Iwasaki</surname> <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-14">CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input</article-title>. <source hwp:id="source-13">Proc Natl Acad Sci U S A</source> <year>2011</year>; <volume>108</volume>: <fpage>8749</fpage>–<lpage>8754</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Bennett SRM"><surname>Bennett</surname> <given-names>SRM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carbone FR"><surname>Carbone</surname> <given-names>FR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karamalis F"><surname>Karamalis</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Flavell RA"><surname>Flavell</surname> <given-names>RA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miller JFAP"><surname>Miller</surname> <given-names>JFAP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heath WR"><surname>Heath</surname> <given-names>WR</given-names></string-name>. <article-title hwp:id="article-title-15">Help for cytotoxic-T-cell responses is mediated by CD4O signalling</article-title>. <source hwp:id="source-14">Nature</source> <year>1998</year>; <volume>393</volume>: <fpage>478</fpage>–<lpage>480</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Dalloul AH"><surname>Dalloul</surname> <given-names>AH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chmouzis E"><surname>Chmouzis</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ngo K"><surname>Ngo</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fung-Leung WP"><surname>Fung-Leung</surname> <given-names>WP</given-names></string-name>. <article-title hwp:id="article-title-16">Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts</article-title>. <source hwp:id="source-15">J Immunol</source> <year>1996</year>; <volume>156</volume>: <fpage>4114</fpage>–<lpage>4119</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Krieger NR"><surname>Krieger</surname> <given-names>NR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yin DP"><surname>Yin</surname> <given-names>DP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fathman CG"><surname>Fathman</surname> <given-names>CG</given-names></string-name>. <article-title hwp:id="article-title-17">CD4+ but not CD8+ cells are essential for allorejection</article-title>. <source hwp:id="source-16">J Exp Med</source> <year>1996</year>; <volume>184</volume>: <fpage>2013</fpage>–<lpage>2018</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Propper DJ"><surname>Propper</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chao D"><surname>Chao</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Braybrooke JP"><surname>Braybrooke</surname> <given-names>JP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bahl P"><surname>Bahl</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thavasu P"><surname>Thavasu</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Balkwill F"><surname>Balkwill</surname> <given-names>F</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-18">Low-Dose IFN-γ Induces Tumor MHC Expression in Metastatic Malignant Melanoma</article-title>. <source hwp:id="source-17">Clin Cancer Res</source> <year>2003</year>; <volume>9</volume>: <fpage>84</fpage>–<lpage>92</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Steimle V"><surname>Steimle</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Otten LA"><surname>Otten</surname> <given-names>LA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zufferey M"><surname>Zufferey</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mach B."><surname>Mach</surname> <given-names>B.</given-names></string-name> <article-title hwp:id="article-title-19">Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)</article-title>. <source hwp:id="source-18">Cell</source> <year>1993</year>; <volume>75</volume>: <fpage>135</fpage>–<lpage>146</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Steimle V"><surname>Steimle</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Siegrist CA"><surname>Siegrist</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mottet A"><surname>Mottet</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lisowska-Grospierre B"><surname>Lisowska-Grospierre</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mach B."><surname>Mach</surname> <given-names>B.</given-names></string-name> <article-title hwp:id="article-title-20">Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA</article-title>. <source hwp:id="source-19">Science (80-)</source> <year>1994</year>; <volume>265</volume>: <fpage>106</fpage>–<lpage>109</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1 xref-ref-20-2 xref-ref-20-3 xref-ref-20-4"><label>20</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Gobin SJP"><surname>Gobin</surname> <given-names>SJP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peijnenburg A"><surname>Peijnenburg</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Keijsers V"><surname>Keijsers</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Den Elsen PJ"><surname>Van Den Elsen</surname> <given-names>PJ</given-names></string-name>. <article-title hwp:id="article-title-21">Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA</article-title>. <source hwp:id="source-20">Immunity</source> <year>1997</year>; <volume>6</volume>: <fpage>601</fpage>–<lpage>611</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2 xref-ref-21-3 xref-ref-21-4"><label>21</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Martin BK"><surname>Martin</surname> <given-names>BK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chin KC"><surname>Chin</surname> <given-names>KC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Olsen JC"><surname>Olsen</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Skinner CA"><surname>Skinner</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dey A"><surname>Dey</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ozato K"><surname>Ozato</surname> <given-names>K</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-22">Induction of MHC class I expression by the MHC class II transactivator CIITA</article-title>. <source hwp:id="source-21">Immunity</source> <year>1997</year>; <volume>6</volume>: <fpage>591</fpage>–<lpage>600</lpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2"><label>22</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Pearse A-M"><surname>Pearse</surname> <given-names>A-M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Swift K"><surname>Swift</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hodson P"><surname>Hodson</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hua B"><surname>Hua</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="McCallum H"><surname>McCallum</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pyecroft S"><surname>Pyecroft</surname> <given-names>S</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-23">Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population</article-title>. <source hwp:id="source-22">Cancer Genet</source> <year>2012</year>; <volume>205</volume>: <fpage>101</fpage>–<lpage>112</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Kowarz E"><surname>Kowarz</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Löscher D"><surname>Löscher</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marschalek R."><surname>Marschalek</surname> <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-24">Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines</article-title>. <source hwp:id="source-23">Biotechnol J</source> <year>2015</year>; <volume>10</volume>: <fpage>647</fpage>–<lpage>653</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Flies AS"><surname>Flies</surname> <given-names>AS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Darby JM"><surname>Darby</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Murphy PR"><surname>Murphy</surname> <given-names>PR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pinfold TL"><surname>Pinfold</surname> <given-names>TL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patchett AL"><surname>Patchett</surname> <given-names>AL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lennard PR"><surname>Lennard</surname> <given-names>PR</given-names></string-name>. <article-title hwp:id="article-title-25">Generation and Testing of Fluorescent Adaptable Simple Theranostic (FAST) Proteins</article-title>. <source hwp:id="source-24">Bioprotocol</source> <year>2020</year>; <volume>10</volume>: <fpage>e3696</fpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Mátés L"><surname>Mátés</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chuah MKL"><surname>Chuah</surname> <given-names>MKL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Belay E"><surname>Belay</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jerchow B"><surname>Jerchow</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Manoj N"><surname>Manoj</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Acosta-Sanchez A"><surname>Acosta-Sanchez</surname> <given-names>A</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-26">Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates</article-title>. <source hwp:id="source-25">Nat Genet</source> <year>2009</year>; <volume>41</volume>: <fpage>753</fpage>–<lpage>761</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Patchett AL"><surname>Patchett</surname> <given-names>AL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wilson R"><surname>Wilson</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Charlesworth JC"><surname>Charlesworth</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Corcoran LM"><surname>Corcoran</surname> <given-names>LM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Papenfuss AT"><surname>Papenfuss</surname> <given-names>AT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lyons BA"><surname>Lyons</surname> <given-names>BA</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-27">Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells</article-title>. <source hwp:id="source-26">Oncotarget</source> <year>2018</year>; <volume>9</volume>: <fpage>15895</fpage>–<lpage>15914</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2 xref-ref-27-3"><label>27</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Patchett AL"><surname>Patchett</surname> <given-names>AL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coorens THH"><surname>Coorens</surname> <given-names>THH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Darby J"><surname>Darby</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wilson R"><surname>Wilson</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="McKay MJ"><surname>McKay</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kamath KS"><surname>Kamath</surname> <given-names>KS</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-28">Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii)</article-title>. <source hwp:id="source-27">Cell Mol Life Sci</source> <year>2020</year>; <volume>77</volume>: <fpage>1847</fpage>–<lpage>1858</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><label>28</label><citation publication-type="website" citation-type="web" ref:id="2021.07.14.452299v2.28" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Andrews S."><surname>Andrews</surname> <given-names>S.</given-names></string-name> <source hwp:id="source-28">FastQC: A Quality Control tool for High Throughput Sequence Data</source>. <year>2010</year>. doi:<ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/" ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/" hwp:id="ext-link-1">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>29</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Liao Y"><surname>Liao</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smyth GK"><surname>Smyth</surname> <given-names>GK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shi W."><surname>Shi</surname> <given-names>W.</given-names></string-name> <article-title hwp:id="article-title-29">The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote</article-title>. <source hwp:id="source-29">Nucleic Acids Res</source> <year>2013</year>; <volume>41</volume>: <fpage>e108</fpage>–<lpage>e108</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Liao Y"><surname>Liao</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smyth GK"><surname>Smyth</surname> <given-names>GK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shi W."><surname>Shi</surname> <given-names>W.</given-names></string-name> <article-title hwp:id="article-title-30">featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source hwp:id="source-30">Bioinformatics</source> <year>2014</year>; <volume>30</volume>: <fpage>923</fpage>–<lpage>930</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31</label><citation publication-type="website" citation-type="web" ref:id="2021.07.14.452299v2.31" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-31"><collab hwp:id="collab-1">RStudio Team</collab>. <source hwp:id="source-31">RStudio: Integrated Development Environment for R</source>. <year>2020</year>. <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.rstudio.com/" ext-link-type="uri" xlink:href="http://www.rstudio.com/" hwp:id="ext-link-2">http://www.rstudio.com/</ext-link>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32</label><citation publication-type="website" citation-type="web" ref:id="2021.07.14.452299v2.32" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-32"><collab hwp:id="collab-2">R Core Team</collab>. <source hwp:id="source-32">R: A Language and Environment for Statistical Computing</source>. <year>2020</year>.<ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.r-project.org/" ext-link-type="uri" xlink:href="https://www.r-project.org/" hwp:id="ext-link-3">https://www.r-project.org/</ext-link>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Robinson MD"><surname>Robinson</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="McCarthy DJ"><surname>McCarthy</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smyth GK"><surname>Smyth</surname> <given-names>GK</given-names></string-name>. <article-title hwp:id="article-title-31">edgeR: A Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source hwp:id="source-33">Bioinformatics</source> <year>2009</year>; <volume>26</volume>: <fpage>139</fpage>–<lpage>140</lpage>.</citation></ref><ref id="c34" hwp:id="ref-34"><label>34</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Robinson MD"><surname>Robinson</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Oshlack A."><surname>Oshlack</surname> <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-32">A scaling normalization method for differential expression analysis of RNA-seq data</article-title>. <source hwp:id="source-34">Genome Biol</source> <year>2010</year>; <volume>11</volume>: <fpage>R25</fpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Anders S"><surname>Anders</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huber W."><surname>Huber</surname> <given-names>W.</given-names></string-name> <article-title hwp:id="article-title-33">Differential expression analysis for sequence count data</article-title>. <source hwp:id="source-35">Genome Biol</source> <year>2010</year>; <volume>11</volume>: <fpage>R106</fpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Bullard JH"><surname>Bullard</surname> <given-names>JH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Purdom E"><surname>Purdom</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hansen KD"><surname>Hansen</surname> <given-names>KD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dudoit S."><surname>Dudoit</surname> <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-34">Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments</article-title>. <source hwp:id="source-36">BMC Bioinformatics</source> <year>2010</year>; <volume>11</volume>: <fpage>94</fpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Risso D"><surname>Risso</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schwartz K"><surname>Schwartz</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sherlock G"><surname>Sherlock</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dudoit S."><surname>Dudoit</surname> <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-35">GC-Content Normalization for RNA-Seq Data</article-title>. <source hwp:id="source-37">BMC Bioinformatics</source> <year>2011</year>; <volume>12</volume>: <fpage>480</fpage>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Law CW"><surname>Law</surname> <given-names>CW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen Y"><surname>Chen</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shi W"><surname>Shi</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smyth GK"><surname>Smyth</surname> <given-names>GK</given-names></string-name>. <article-title hwp:id="article-title-36">voom: Precision weights unlock linear model analysis tools for RNA-seq read counts</article-title>. <source hwp:id="source-38">Genome Biol</source> <year>2014</year>; <volume>15</volume>: <fpage>R29</fpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Ritchie ME"><surname>Ritchie</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Phipson B"><surname>Phipson</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu D"><surname>Wu</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hu Y"><surname>Hu</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Law CW"><surname>Law</surname> <given-names>CW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shi W"><surname>Shi</surname> <given-names>W</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-37">limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source hwp:id="source-39">Nucleic Acids Res</source> <year>2015</year>; <volume>43</volume>: <fpage>e47</fpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>40</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Phipson B"><surname>Phipson</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee S"><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Majewski IJ"><surname>Majewski</surname> <given-names>IJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alexander WS"><surname>Alexander</surname> <given-names>WS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smyth GK"><surname>Smyth</surname> <given-names>GK</given-names></string-name>. <article-title hwp:id="article-title-38">Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression</article-title>. <source hwp:id="source-40">Ann Appl Stat</source> <year>2016</year>; <volume>10</volume>: <fpage>946</fpage>–<lpage>963</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41</label><citation publication-type="website" citation-type="web" ref:id="2021.07.14.452299v2.41" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Oliveros JC"><surname>Oliveros</surname> <given-names>JC</given-names></string-name>. <article-title hwp:id="article-title-39">Venny</article-title>. <source hwp:id="source-41">An interactive tool for comparing lists with Venn’s diagrams</source>. <year>2015</year>.<ext-link l:rel="related" l:ref-type="uri" l:ref="https://bioinfogp.cnb.csic.es/tools/venny/index.html" ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html" hwp:id="ext-link-4">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>42</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Gu Z"><surname>Gu</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eils R"><surname>Eils</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schlesner M."><surname>Schlesner</surname> <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-40">Complex heatmaps reveal patterns and correlations in multidimensional genomic data</article-title>. <source hwp:id="source-42">Bioinformatics</source> <year>2016</year>; <volume>32</volume>: <fpage>2847</fpage>–<lpage>2849</lpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><label>43</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Huang DW"><surname>Huang</surname> <given-names>DW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sherman BT"><surname>Sherman</surname> <given-names>BT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lempicki RA"><surname>Lempicki</surname> <given-names>RA</given-names></string-name>. <article-title hwp:id="article-title-41">Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists</article-title>. <source hwp:id="source-43">Nucleic Acids Res</source> <year>2009</year>; <volume>37</volume>: <fpage>1</fpage>–<lpage>13</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><label>44</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Huang DW"><surname>Huang</surname> <given-names>DW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sherman BT"><surname>Sherman</surname> <given-names>BT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lempicki RA"><surname>Lempicki</surname> <given-names>RA</given-names></string-name>. <article-title hwp:id="article-title-42">Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source hwp:id="source-44">Nat Protoc</source> <year>2009</year>; <volume>4</volume>: <fpage>44</fpage>–<lpage>57</lpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>45</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Cheng Y"><surname>Cheng</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stuart A"><surname>Stuart</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morris K"><surname>Morris</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Taylor R"><surname>Taylor</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Siddle H"><surname>Siddle</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deakin J"><surname>Deakin</surname> <given-names>J</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-43">Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC</article-title>. <source hwp:id="source-45">BMC Genomics</source> <year>2012</year>; <volume>13</volume>: <fpage>87</fpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Flies AS"><surname>Flies</surname> <given-names>AS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lyons AB"><surname>Lyons</surname> <given-names>AB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Corcoran LM"><surname>Corcoran</surname> <given-names>LM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Papenfuss AT"><surname>Papenfuss</surname> <given-names>AT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Murphy JM"><surname>Murphy</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knowles GW"><surname>Knowles</surname> <given-names>GW</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-44">PD-L1 is not constitutively expressed on Tasmanian devil facial tumor cells but is strongly upregulated in response to IFN-γ and can be expressed in the tumor 1 microenvironment</article-title>. <source hwp:id="source-46">Front Immunol</source> <year>2016</year>; <volume>7</volume>: <fpage>581</fpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>47</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Howson LJ"><surname>Howson</surname> <given-names>LJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morris KM"><surname>Morris</surname> <given-names>KM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kobayashi T"><surname>Kobayashi</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tovar C"><surname>Tovar</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kreiss A"><surname>Kreiss</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Papenfuss AT"><surname>Papenfuss</surname> <given-names>AT</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-45">Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors</article-title>. <source hwp:id="source-47">Anat Rec (Hoboken)</source> <year>2014</year>; <volume>297</volume>: <fpage>925</fpage>–<lpage>938</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><label>48</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Caplen HS"><surname>Caplen</surname> <given-names>HS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salvadori S"><surname>Salvadori</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gansbacher B"><surname>Gansbacher</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zier KS"><surname>Zier</surname> <given-names>KS</given-names></string-name>. <article-title hwp:id="article-title-46">Post-transcriptional regulation of MHC class II expression in human T cells</article-title>. <source hwp:id="source-48">Cell Immunol</source> <year>1992</year>; <volume>139</volume>: <fpage>98</fpage>–<lpage>107</lpage>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>49</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Otten LA"><surname>Otten</surname> <given-names>LA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Steimle V"><surname>Steimle</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bontron S"><surname>Bontron</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mach B."><surname>Mach</surname> <given-names>B.</given-names></string-name> <article-title hwp:id="article-title-47">Quantitative control of MHC class II expression by the transactivator CIITA</article-title>. <source hwp:id="source-49">Eur J Immunol</source> <year>1998</year>; <volume>28</volume>: <fpage>473</fpage>–<lpage>478</lpage>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><label>50</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Gobin SJP"><surname>Gobin</surname> <given-names>SJP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peijnenburg A"><surname>Peijnenburg</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Eggermond M"><surname>Van Eggermond</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Zutphen M"><surname>Van Zutphen</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Den Berg R"><surname>Van Den Berg</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Den Elsen PJ"><surname>Van Den Elsen</surname> <given-names>PJ</given-names></string-name>. <article-title hwp:id="article-title-48">The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and β2-microglobulin genes</article-title>. <source hwp:id="source-50">Immunity</source> <year>1998</year>; <volume>9</volume>: <fpage>531</fpage>–<lpage>541</lpage>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1 xref-ref-51-2"><label>51</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Masternak K"><surname>Masternak</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Muhlethaler-Mottet A"><surname>Muhlethaler-Mottet</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Villard J"><surname>Villard</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zufferey M"><surname>Zufferey</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Steimle V"><surname>Steimle</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reith W."><surname>Reith</surname> <given-names>W.</given-names></string-name> <article-title hwp:id="article-title-49">CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex</article-title>. <source hwp:id="source-51">Genes Dev</source> <year>2000</year>; <volume>14</volume>: <fpage>1156</fpage>–<lpage>1166</lpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><label>52</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Leen MPJM"><surname>Leen</surname> <given-names>MPJM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gorski J."><surname>Gorski</surname> <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-50">Differential expression of isomorphic HLA-DRβ genes is not a sole function of transcription</article-title>. <source hwp:id="source-52">Hum Immunol</source> <year>1996</year>; <volume>50</volume>: <fpage>111</fpage>–<lpage>120</lpage>.</citation></ref><ref id="c53" hwp:id="ref-53"><label>53</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Kulkarni S"><surname>Kulkarni</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Savan R"><surname>Savan</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qi Y"><surname>Qi</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gao X"><surname>Gao</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yuki Y"><surname>Yuki</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bass SE"><surname>Bass</surname> <given-names>SE</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-51">Differential microRNA regulation of HLA-C expression and its association with HIV control</article-title>. <source hwp:id="source-53">Nature</source> <year>2011</year>; <volume>472</volume>: <fpage>495</fpage>–<lpage>498</lpage>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><label>54</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Andersen LC"><surname>Andersen</surname> <given-names>LC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Beaty JS"><surname>Beaty</surname> <given-names>JS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nettles JW"><surname>Nettles</surname> <given-names>JW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seyfried CE"><surname>Seyfried</surname> <given-names>CE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nepom GT"><surname>Nepom</surname> <given-names>GT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nepom BS"><surname>Nepom</surname> <given-names>BS</given-names></string-name>. <article-title hwp:id="article-title-52">Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes</article-title>. <source hwp:id="source-54">J Exp Med</source> <year>1991</year>; <volume>173</volume>: <fpage>181</fpage>–<lpage>192</lpage>.</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><label>55</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Gobin SJP"><surname>Gobin</surname> <given-names>SJP</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Zutphen M"><surname>van Zutphen</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Westerheide SD"><surname>Westerheide</surname> <given-names>SD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Boss JM"><surname>Boss</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="van den Elsen PJ"><surname>van den Elsen</surname> <given-names>PJ</given-names></string-name>. <article-title hwp:id="article-title-53">The MHC-specific enhanceosome and its role in MHC class I and β2-microglobulin gene transactivation</article-title>. <source hwp:id="source-55">J Immunol</source> <year>2001</year>; <volume>167</volume>: <fpage>5175</fpage>–<lpage>5184</lpage>.</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><label>56</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Meissner TB"><surname>Meissner</surname> <given-names>TB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu Y-J"><surname>Liu</surname> <given-names>Y-J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee K-H"><surname>Lee</surname> <given-names>K-H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li A"><surname>Li</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Biswas A"><surname>Biswas</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Eggermond MCJA"><surname>van Eggermond</surname> <given-names>MCJA</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-54">NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression</article-title>. <source hwp:id="source-56">J Immunol</source> <year>2012</year>; <volume>188</volume>: <fpage>4951</fpage>–<lpage>4958</lpage>.</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><label>57</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Hsiao YW"><surname>Hsiao</surname> <given-names>YW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liao KW"><surname>Liao</surname> <given-names>KW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hung SW"><surname>Hung</surname> <given-names>SW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chu RM"><surname>Chu</surname> <given-names>RM</given-names></string-name>. <article-title hwp:id="article-title-55">Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells</article-title>. <source hwp:id="source-57">Vet Immunol Immunopathol</source> <year>2002</year>; <volume>87</volume>: <fpage>19</fpage>–<lpage>27</lpage>.</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1"><label>58</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Hsiao Y-W"><surname>Hsiao</surname> <given-names>Y-W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liao K-W"><surname>Liao</surname> <given-names>K-W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chung T-F"><surname>Chung</surname> <given-names>T-F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu C-H"><surname>Liu</surname> <given-names>C-H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hsu C-D"><surname>Hsu</surname> <given-names>C-D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chu R-M."><surname>Chu</surname> <given-names>R-M.</given-names></string-name> <article-title hwp:id="article-title-56">Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression</article-title>. <source hwp:id="source-58">Cancer Immunol Immunother</source> <year>2008</year>; <volume>57</volume>: <fpage>1091</fpage>–<lpage>1104</lpage>.</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1"><label>59</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Murchison EP"><surname>Murchison</surname> <given-names>EP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tovar C"><surname>Tovar</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hsu A"><surname>Hsu</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bender HS"><surname>Bender</surname> <given-names>HS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kheradpour P"><surname>Kheradpour</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rebbeck CA"><surname>Rebbeck</surname> <given-names>CA</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-57">The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer</article-title>. <source hwp:id="source-59">Science</source> <year>2010</year>; <volume>327</volume>: <fpage>84</fpage>–<lpage>87</lpage>.</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1"><label>60</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Meyer zu"><surname>Meyer</surname> <given-names>zu</given-names></string-name> <string-name name-style="western" hwp:sortable="Hörste G"><surname>Hörste</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heidenreich H"><surname>Heidenreich</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lehmann HC"><surname>Lehmann</surname> <given-names>HC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferrone S"><surname>Ferrone</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hartung HP"><surname>Hartung</surname> <given-names>HP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wiendl H"><surname>Wiendl</surname> <given-names>H</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-58">Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies</article-title>. <source hwp:id="source-60">Glia</source> <year>2010</year>; <volume>58</volume>: <fpage>80</fpage>–<lpage>92</lpage>.</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><label>61</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="zu Meyer"><given-names>Meyer</given-names> <surname>zu</surname></string-name> <string-name name-style="western" hwp:sortable="Hörste G"><surname>Hörste</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heidenreich H"><surname>Heidenreich</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mausberg AK"><surname>Mausberg</surname> <given-names>AK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lehmann HC"><surname>Lehmann</surname> <given-names>HC</given-names></string-name>, <string-name name-style="western" hwp:sortable="ten Asbroek ALMA"><surname>ten Asbroek</surname> <given-names>ALMA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Saavedra JT"><surname>Saavedra</surname> <given-names>JT</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-59">Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation</article-title>. <source hwp:id="source-61">Neurobiol Dis</source> <year>2010</year>; <volume>37</volume>: <fpage>483</fpage>–<lpage>490</lpage>.</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1"><label>62</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Meazza R"><surname>Meazza</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Comes A"><surname>Comes</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Orengo AM"><surname>Orengo</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferrini S"><surname>Ferrini</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Accolla RS"><surname>Accolla</surname> <given-names>RS</given-names></string-name>. <article-title hwp:id="article-title-60">Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells</article-title>. <source hwp:id="source-62">Eur J Immunol</source> <year>2003</year>; <volume>33</volume>: <fpage>1183</fpage>–<lpage>1192</lpage>.</citation></ref><ref id="c63" hwp:id="ref-63"><label>63</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Mortara L"><surname>Mortara</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frangione V"><surname>Frangione</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Castellani P"><surname>Castellani</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="De Lerma Barbaro A"><surname>De Lerma Barbaro</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Accolla RS"><surname>Accolla</surname> <given-names>RS</given-names></string-name>. <article-title hwp:id="article-title-61">Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions</article-title>. <source hwp:id="source-63">Int Immunol</source> <year>2009</year>; <volume>21</volume>: <fpage>655</fpage>–<lpage>665</lpage>.</citation></ref><ref id="c64" hwp:id="ref-64"><label>64</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Frangione V"><surname>Frangione</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mortara L"><surname>Mortara</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Castellani P"><surname>Castellani</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="De Lerma Barbaro A"><surname>De Lerma Barbaro</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Accolla RS"><surname>Accolla</surname> <given-names>RS</given-names></string-name>. <article-title hwp:id="article-title-62">CIITA-driven MHC-II positive tumor cells: Preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy</article-title>. <source hwp:id="source-64">Int J Cancer</source> <year>2010</year>; <volume>127</volume>: <fpage>1614</fpage>–<lpage>1624</lpage>.</citation></ref><ref id="c65" hwp:id="ref-65"><label>65</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Ekkirala CR"><surname>Ekkirala</surname> <given-names>CR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cappello P"><surname>Cappello</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Accolla RS"><surname>Accolla</surname> <given-names>RS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Giovarelli M"><surname>Giovarelli</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romero I"><surname>Romero</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Garrido C"><surname>Garrido</surname> <given-names>C</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-63">Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response</article-title>. <source hwp:id="source-65">Pancreas</source> <year>2014</year>; <volume>43</volume>: <fpage>1066</fpage>–<lpage>1072</lpage>.</citation></ref><ref id="c66" hwp:id="ref-66"><label>66</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Ostrand-Rosenberg S"><surname>Ostrand-Rosenberg</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clements VK"><surname>Clements</surname> <given-names>VK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thakur A"><surname>Thakur</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cole GA"><surname>Cole</surname> <given-names>GA</given-names></string-name>. <article-title hwp:id="article-title-64">Transfection of major histocompatibility complex class I and class II genes causes tumour rejection</article-title>. <source hwp:id="source-66">Int J Immunogenet</source> <year>1989</year>; <volume>16</volume>: <fpage>343</fpage>–<lpage>349</lpage>.</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><label>67</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.14.452299v2.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Ostrand-Rosenberg S"><surname>Ostrand-Rosenberg</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thakur A"><surname>Thakur</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clements V."><surname>Clements</surname> <given-names>V.</given-names></string-name> <article-title hwp:id="article-title-65">Rejection of mouse sarcoma cells after transfection of MHC class II genes</article-title>. <source hwp:id="source-67">J Immunol</source> <year>1990</year>; <volume>144</volume>: <fpage>4068</fpage>–<lpage>4071</lpage>.</citation></ref></ref-list></back></article>
